Skip to content

Study on the Construction of an Intervention System for Sleep Perception Disorders in Patients with Depression Based on Sleep Stage tACS Technology

Study on the Construction of an Intervention System for Sleep Perception Disorders in Patients with Depression Based on Sleep Stage tACS Technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099818
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Intervention group:Transcranial alternating current stimulation
Control group:Sham stimulation

Sponsors

Beijing Huilongguan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years, with an educational level of junior high school or above. 2. Meet the diagnostic criteria for a depressive episode according to the International Classification of Diseases, 10th Revision (ICD-10). 3. The discrepancy between subjective sleep duration and objective total sleep time is >=60 minutes, or the difference between subjective sleep efficiency and objective sleep efficiency is >=15%. 4. In the past two weeks, apart from taking escitalopram oxalate and zopiclone, no other sedative-hypnotic drugs, antidepressants, antipsychotic medications, or hormonal therapies have been used. 5. Patients voluntarily participate in the study, understand the content of the study, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe physical illness with unstable health status (e.g., hypertensive patients whose blood pressure is not controlled within the normal range). 2. Concurrent intellectual disability or organic brain disease. 3. Substance use disorder. 4. Presence of other sleep-affecting disorders such as sleep apnea syndrome, central hypersomnia, parasomnia, or sleep-related movement disorders. 5. Received repetitive transcranial magnetic stimulation, electroconvulsive therapy without convulsions, transcranial electrical stimulation, or cognitive behavioral therapy within the past three months. 6. Presence of metal implants in the body, such as cardiac pacemakers or brain stimulators. 7. Allergy to electrode pad materials, specifically silicone. 8. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Subjective sleep;Anxiety symptoms;Depressive symptoms;Fatigue severity;Disease severity;Cognitive function;Objective sleep;Social function;Adverse effects of treatment;Inflammatory cytokines;

Countries

China

Contacts

Public ContactShuangjiang Zhou

Beijing Huilongguan Hospital

zhoushuangjiang@126.com+86 134 6640 1377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026